Interpretable Drug Synergy Prediction with Graph Neural Networks for
  Human-AI Collaboration in Healthcare
  We investigate molecular mechanisms of resistant or sensitive response of
cancer drug combination therapies in an inductive and interpretable manner.
Though deep learning algorithms are widely used in the drug synergy prediction
problem, it is still an open problem to formulate the prediction model with
biological meaning to investigate the mysterious mechanisms of synergy (MoS)
for the human-AI collaboration in healthcare systems. To address the
challenges, we propose a deep graph neural network, IDSP (Interpretable Deep
Signaling Pathways), to incorporate the gene-gene as well as gene-drug
regulatory relationships in synergic drug combination predictions. IDSP
automatically learns weights of edges based on the gene and drug node
relations, i.e., signaling interactions, by a multi-layer perceptron (MLP) and
aggregates information in an inductive manner. The proposed architecture
generates interpretable drug synergy prediction by detecting important
signaling interactions, and can be implemented when the underlying molecular
mechanism encounters unseen genes or signaling pathways. We test IDWSP on
signaling networks formulated by genes from 46 core cancer signaling pathways
and drug combinations from NCI ALMANAC drug combination screening data. The
experimental results demonstrated that 1) IDSP can learn from the underlying
molecular mechanism to make prediction without additional drug chemical
information while achieving highly comparable performance with current
state-of-art methods; 2) IDSP show superior generality and flexibility to
implement the synergy prediction task on both transductive tasks and inductive
tasks. 3) IDSP can generate interpretable results by detecting different
salient signaling patterns (i.e. MoS) for different cell lines.
